Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • weitere Studien Pharmaindustrie / Medikamente
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Island
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Luxemburg
  • Malta
  • Mazedonien
  • Moldawien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Zypern
  • Asien / Pazifik
  • Bangladesch
  • China
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Ghana
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Oman
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • AIK - Kohlhaas & Partner
  • Biopharm Reports
  • Business Insights
  • Canadean
  • cbc market intelligence
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • Global Research & Data Services
  • GlobalData
  • ICD Research
  • Koncept Analytics
  • Life Science Analytics
  • MarketLine
  • MarketsandMarkets
  • Pesquisa GmbH
  • Technavio
  • Verdict
  • Zukunftsinstitut
  • Filter zurücksetzen
Sprache
  • Deutsch
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • Filter zurücksetzen
laedt

Marktanalyse - Calming and Sleeping in Hungary

Euromonitor

Euromonitor

7 / 2012
30 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Ungarn
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

675,00 €*
PDF-Datei per E-Mail , versandkostenfrei


Hectic lifestyles, cumulating personal problems caused by the economic downturn and rising pressure on people, affected both value and volume sales of calming and sleeping products positively in 2011. Many Hungarians prefer trying non-prescription calming and sleeping product before visiting the doctor for Rx medicines, since they are afraid of getting used to chemicals and suffering from side-effects. Moreover, doctors also suggest non-prescription products as a first step in treatment as...

Euromonitor International's Calming and Sleeping in Hungary report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
CALMING AND SLEEPING IN HUNGARY

Euromonitor International

July 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Calming and Sleeping: Value 2006-2011

Table 2 Sales of Calming and Sleeping: % Value Growth 2006-2011

Table 3 Calming and Sleeping Company Shares by Value 2007-2011

Table 4 Calming and Sleeping Brand Shares by Value 2008-2011

Table 5 Forecast Sales of Calming and Sleeping: Value 2011-2016

Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Béres Gyógyszergyár Zrt in Consumer Health (hungary)

Strategic Direction

Key Facts

Summary 1 Béres Gyógyszergyár Zrt: Key Facts

Summary 2 Béres Gyógyszergyár Zrt: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 3 Béres Gyógyszergyár Zrt: Competitive Position 2011

Executive Summary

Moderate Growth With Decreasing Constant Sales

Manufacturers Invest Heavily in Advertising

Multinationals Dominate Consumer Health

Chemists/pharmacies Preserves Its Leading Role in Distribution

Steady Growth Is Predicted Over Forecast Period

Key Trends and Developments

Lengthening Economic Crisis, Deepening Debt Crisis

Pharmacies in Difficult Situation

Moderate Product Development, Massive Advertising

Central European Regulation of Health Claims Determines Innovation Trends in Vitamins and Dietary Supplements

New Age Arrived for Smokers

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 8 Life Expectancy at Birth 2006-2011

Market Data

Table 9 Sales of Consumer Health by Category: Value 2006-2011

Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 11 Consumer Health Company Shares 2007-2011

Table 12 Consumer Health Brand Shares 2008-2011

Table 13 Penetration of Private Label by Category 2006-2011

Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

Summary 4 OTC Switches 2009-2011

Sources

Summary 5 Research Sources

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: